Home » Topics » BioWorld Science

BioWorld Science
RSS

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

Folic acid therapy and cardiovascular risk reduction

Jan. 29, 1998

Hybridon antitumor antisense compound enters clinical trials

Jan. 29, 1998

Optison imaging agent launched in U.S.

Jan. 29, 1998

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Long-term efficacy of epoprostenol for primary pulmonary hypertension

Jan. 29, 1998

Swiss Remune trials initiated

Jan. 29, 1998

Comparative trial of intracavernous alprostadil and MUSE for ED

Jan. 29, 1998

ArQule and CuraGen establish broad drug discovery collaboration

Jan. 29, 1998

Diphenylalkylamine derivative with cardioprotective properties characterized

Jan. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...